Gene Expression Regulation, Neoplastic
"Gene Expression Regulation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.
Descriptor ID |
D015972
|
MeSH Number(s) |
G05.308.370
|
Concept/Terms |
Gene Expression Regulation, Neoplastic- Gene Expression Regulation, Neoplastic
- Regulation of Gene Expression, Neoplastic
- Regulation, Gene Expression, Neoplastic
- Neoplastic Gene Expression Regulation
|
Below are MeSH descriptors whose meaning is more general than "Gene Expression Regulation, Neoplastic".
Below are MeSH descriptors whose meaning is more specific than "Gene Expression Regulation, Neoplastic".
This graph shows the total number of publications written about "Gene Expression Regulation, Neoplastic" by people in this website by year, and whether "Gene Expression Regulation, Neoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 1 | 3 |
1995 | 3 | 0 | 3 |
1996 | 2 | 4 | 6 |
1997 | 2 | 2 | 4 |
1998 | 4 | 4 | 8 |
1999 | 4 | 4 | 8 |
2000 | 3 | 4 | 7 |
2001 | 3 | 4 | 7 |
2002 | 8 | 12 | 20 |
2003 | 9 | 9 | 18 |
2004 | 7 | 17 | 24 |
2005 | 12 | 17 | 29 |
2006 | 15 | 25 | 40 |
2007 | 23 | 22 | 45 |
2008 | 15 | 18 | 33 |
2009 | 15 | 23 | 38 |
2010 | 12 | 26 | 38 |
2011 | 17 | 29 | 46 |
2012 | 17 | 33 | 50 |
2013 | 19 | 32 | 51 |
2014 | 14 | 38 | 52 |
2015 | 22 | 31 | 53 |
2016 | 15 | 40 | 55 |
2017 | 15 | 37 | 52 |
2018 | 11 | 38 | 49 |
2019 | 6 | 24 | 30 |
2020 | 10 | 27 | 37 |
2021 | 8 | 20 | 28 |
2022 | 1 | 10 | 11 |
2023 | 0 | 1 | 1 |
2024 | 3 | 12 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Expression Regulation, Neoplastic" by people in Profiles.
-
HYENA detects oncogenes activated by distal enhancers in cancer. Nucleic Acids Res. 2024 Sep 09; 52(16):e77.
-
IGF2BP3 promotes mRNA degradation through internal m7G modification. Nat Commun. 2024 Aug 28; 15(1):7421.
-
Emerin deficiency drives MCF7 cells to an invasive phenotype. Sci Rep. 2024 08 28; 14(1):19998.
-
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. Nat Genet. 2024 Sep; 56(9):1878-1889.
-
Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic Signatures. Cancer Res Commun. 2024 Aug 01; 4(8):2255-2266.
-
Association of KRAS Mutation and Gene Pathways in Colorectal Carcinoma: A Transcriptome- and Methylome-Wide Study and Potential Implications for Therapy. Int J Mol Sci. 2024 Jul 25; 25(15).
-
Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies. Cancer Cell. 2024 Aug 12; 42(8):1336-1351.e9.
-
Multi-tissue transcriptome-wide association studies identified 235 genes for intrinsic subtypes of breast cancer. J Natl Cancer Inst. 2024 Jul 01; 116(7):1105-1115.
-
Molecular Profiling and the Interaction of Somatic Mutations with Transcriptomic Profiles in Non-Melanoma Skin Cancer (NMSC) in a Population Exposed to Arsenic. Cells. 2024 Jun 18; 13(12).
-
The VEGF-Hypoxia Signature Is Upregulated in Basal-like Breast Tumors from Women of African Ancestry and Associated with Poor Outcomes in Breast Cancer. Clin Cancer Res. 2024 Jun 03; 30(11):2609-2618.